Chemical Biology for Target Validation 2015 | Targeting the Stress Chaperome in Cancer

CHI interviews Dr. Gabriela Chiosis, Associate Member and Lab Head of Molecular Pharmacology and Chemistry at Memorial Sloan Kettering Cancer Center about the trends, tools and challenges in developing chaperome-based therapeutics. Discussion questions include: 1. How have you seen this field evolve over the past few years? 2. Can you share with us what we have learned from discovery and clinical efforts thus far? 3. What tools have recently been developed, including those from your lab, that are currently advancing drug discovery in this space? 4. What are the remaining challenges surrounding drug discovery and development in this space? What has hindered FDA approvals? 5. You are giving a lecture during the upcoming Chemical Biology for Target Validation meeting, June 10-11 in Boston – part of the World Pharma Congress 2015. What do you hope to convey to attendees during your lecture? 6. Where do you see the greatest opportunities for continued development? For more information visit http://www.Healthtech.com/Chemical-Biology-Proteomics